Basit öğe kaydını göster

The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens.

dc.contributor.authorSAVAS, B
dc.contributor.authorPehlivan, Sacide
dc.contributor.authorOZDOGAN, M
dc.contributor.authorARTAC, M
dc.contributor.authorBOZCUK, H
dc.contributor.authorAKCAN, S
dc.contributor.authorPEHLIVAN, M
dc.contributor.authorSEVER, T
dc.date.accessioned2021-03-03T19:07:59Z
dc.date.available2021-03-03T19:07:59Z
dc.identifier.citationARTAC M., BOZCUK H., Pehlivan S., AKCAN S., PEHLIVAN M., SEVER T., OZDOGAN M., SAVAS B., "The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens.", Journal of cancer research and clinical oncology, cilt.136, ss.803-9, 2010
dc.identifier.issn0171-5216
dc.identifier.othervv_1032021
dc.identifier.otherav_52e0cee7-59d7-4527-96df-b410a02bee50
dc.identifier.urihttp://hdl.handle.net/20.500.12627/58803
dc.identifier.urihttps://doi.org/10.1007/s00432-009-0720-3
dc.language.isoeng
dc.titleThe value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens.
dc.typeMakale
dc.relation.journalJournal of cancer research and clinical oncology
dc.contributor.departmentEge Üniversitesi , ,
dc.identifier.volume136
dc.identifier.startpage803
dc.identifier.endpage9
dc.contributor.firstauthorID166995


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster